Skip to main content
. 2022 Jun 27;17(6):e0270607. doi: 10.1371/journal.pone.0270607

Table 3. Relapse free interval: CSF values—multivariate Cox regression modela.

  Group in risk Hazard Ratio P-value
Age at clinical onset (y) <22 4.3 0.0312
EDSS at time of therapy initiation ≥1.5 3.0 0.0481
IL2:IL6 <0.48 7.0 0.0028
IL-2 CSF (pg/ml) ≥1.23 6.1 0.026
CHI3L2 CSF (pg/ml) ≥7900 3.1 0.033
Sex, type of the 1st DMD, IgG calc, IgM calc, IndexIL-2, IndexIL-6, IndexIL-10, IndexCHI3L2, pNfH in serum, IL-6 CSF, IL-10 CSF - - n.s.

y = years; EDSS = Expanded Disability Status Scale; IL-2 = interleukin 2; IL-6 = interleukin 6; CSF = cerebrospinal fluid; CHI3L2 = chitinase 3-like 2 protein; DMD = disease modifying drugs; IgG calc = calculated IgG intrathecal synthesis; IgM calc = calculated IgM intrathecal synthesis; IL-10 = interleukin 10; pNfH = phosphorylated neurofilament heavy chains;— = does not apply; n.s. = non-significant.

aIndicators in brackets correspond to data in "Group in risk" column.